✕
Login
Register
Back to News
HC Wainwright & Co. Reiterates Buy on UroGen Pharma, Maintains $45 Price Target
Benzinga Newsdesk
www.benzinga.com
Neutral 89.9%
Neg 0%
Neu 89.9%
Pos 0%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment